Global Single Cell Multiomics Market 2024–2033

Reports Description

As per the current market research conducted by the CMI Team, the global Single Cell Multiomics Market is expected to record a CAGR of 19.58% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 5.10 Billion. By 2033, the valuation is anticipated to reach USD 18.90 Billion.

The rising prevalence of breast cancer is also a significant driver leading to the growth of this market. According to the National Breast Cancer Foundation, 1 in 8 women in the United States will be diagnosed with breast cancer in their lifetime. In 2024, an estimated 310,720 women and 2,800 men will be diagnosed with invasive breast cancer.

Chances are, you know at least one person who has been personally affected by breast cancer. Black women are more likely to die from breast cancer than women of any other racial or ethnic group. Experts believe that it’s partially because about 1 in 5 Black women is diagnosed with triple-negative breast cancer, more than any other racial or ethnic group.

Breast cancer is the leading cause of cancer-related death in the United States for Black and Hispanic women. Breast cancer is the second-leading cause of cancer-related death in the United States, following lung cancer, for Asian and Pacific Islander women, American Indian and Alaska Native women, and white women.

Single Cell Multiomics Market – Significant Growth Factors

The single cell multiomics market presents significant growth opportunities due to several factors:

• Increasing Demand for Advanced Research Solutions: They also identified a growing demand for accurate and technically efficient multiomics methods for single cell analysis by researchers and research institutions. The trends contributing to the growth and development of advanced multimodality technologies include a comprehensive data analysis integration, the steady performance of the technologies, and better research result outcomes.

• Rise in Biomedical Research and Precision Medicine: Biomedical and precision medicine warrants sophisticated single-cell multiomics solutions. This must also be associated with the increasing focus on biomedical research.

• Technological Advancements: Developments made to the single-cell multiomics technologies have included more effective and efficient sequencing, bioinformatics, and data integration systems that improve the usability of single-cell multiomics systems, which attract research intensities and biotech companies.

• Expansion of Genomics and Proteomics Research: The need for single cell multiomics solutions results from the current global development of genomics and proteomics. Scientists look for simple and effective infrastructures to handle data intensive biological information in a highly interconnected research milieu.

• Growth in Regulatory Requirements: As the multiplicity of data protection regulatory, privacy, and ethical standards continually expands to regulate the use and management of single-cell data, the demand for single-cell multi-omics solutions advances, too. Organizations are expected to have high requirements to guarantee the accuracy of data and credibility of the research done.

• Increase in Remote Research and Collaboration: There are also new opportunities coming from remote research and distributed collaboration in the single-cell multiomics market. This shift requires addressing complex multiomics requirements for the secure sharing and remote data analysis.

• Urbanization and Industrial Growth: High growth rates of urbanization and industrialization, especially in developing countries, encourage demand for complex single-cell multiomics solutions. These regions are experiencing an uplift in using sophisticated multiomics solutions to enhance their growing research frameworks.

• Increasing Investments in Biotechnology: The market for single cell multiomics solutions is increasing thanks to the increasing interest in biotechnology by governments and companies across the globe. This economic factor contributes to such a market expansion and the creation of the new field of multi-omics technologies.

Single Cell Multiomics Market – New Partnership

The Single Cell Multiomics Market has seen several new partnerships in recent years, with companies seeking to expand their market presence and leverage synergies to improve their product offerings and profitability. Some notable examples of product partnerships in the Single Cell Multiomics Market include:

• In July 2024, the Max Delbrück Center and Bruker announced a strategic partnership to build a first-of-its-kind innovation hub for systems medicine. The new center will focus on developing and applying mass spectrometry based single-cell and multi-omics technologies. The Max Delbrück Center and Bruker have launched a strategic collaboration that aims to capitalize on the expertise of both partners to accelerate innovations in systems medicine.

• In February 2024, Scale Biosciences announced its development of a new two plate workflow to dramatically scale its technology and a first set of partners to improve ease of use and enable the deployment of their portfolio across new omics applications. The new platform, announced at the 2024 Advances in Genome Biology and Technology (AGBT) general meeting, allows researchers to prepare sequencing-ready single-cell libraries of up to 2 million cells in an experiment and reduces the plates needed from three to two. This technology will form the basis for future ScaleBio innovation and product development.

• In January 2024, BD (Becton, Dickinson and Company), a medical technology company, announced a collaboration agreement with Hamilton, a global manufacturer of laboratory automation technology, to develop automated applications together with robotics-compatible reagent kits to enable greater standardization and reduced human error when conducting large-scale single-cell multiomics experiments. As a result of the collaboration, BD aims to deliver a suite of BD Rhapsody Single-Cell Analysis Library Preparation Reagent Kits that can be performed on the Hamilton Micro lab NGS STAR robotic liquid-handling platform.

These partnerships helped companies expand their product offerings, improve their market presence, and capitalize on the Single Cell Multiomics Market growth opportunities. The trend is expected to continue as companies seek a competitive edge in the market.

Single Cell Multiomics Market – Significant Threats

The single cell multiomics market faces several significant challenges that could potentially impact its growth and profitability in the future. These threats include:

• Economic Fluctuations: A conversational tone may arise from the fact that economic turbulence that may include recession will reduce the funding of institutes, which in turn may reduce the call for single-cell multiomics solutions. Fluctuations in financial markets could also affect budgets related to academic and other commercial research initiatives.

• Intense Market Competition: The competition in the market is high and the market players are big manufacturers and new entrants. The risks of this competition are related to pricing strategies, decreasing margins, and constant pressure to keep introducing some changes to products to protect the share on the market.

• Technological Advancements: The pace of the development of multiomics technology and bioinformatics may lead to a situation when these solutions will no longer be viable. It becomes obligatory for the companies to bring changes and update new techniques to provide new techniques in research, data integration, and improving analytical skills to meet the increasing research need and standard.

• Supply Chain Challenges: Supply chain issues, including shortages of reagents, transportation problems, or political turmoil at the worldwide level, can also affect the company’s plans with single-cell multiomics solutions and their costs. Having an efficient and defensive supply chain system is important to provide a better product solution.

• Regulatory Requirements: High levels of regulation in biotechnology and data protection may raise the compliance expenditure and place constraints on multi-omics platforms. It is, therefore, challenging for firms to operate within regional frameworks that have strict standards of compliance to set while at the same time, they have to create new solutions and bring them to market.

Category-Wise Insights

By Technology

• Single-cell RNA Sequencing: This technology allows the determination of gene expression at the single-cell level, which adds understanding of the population heterogeneity. This technology helps identify certain low-frequency cell types, understand developmental processes, and dissect tissue microenvironment, which can be beneficial in cancer, immunology, neurobiology applications, etc.

• Single-cell DNA Sequencing: It enables the examination of changes and modifications on genetic differences within each outline of the cell. These features make this technology valuable for the analysis of genome repertoire, clonal evolution of cancer, and genetic mosaicism. The analysis helps identify mutations, which are responsible for disease progression and resistance, which could be useful in precise medicine approaches.

• Single-cell Proteomics: Single-cell proteomics is, therefore, the study of proteins at the level of a single cell. In this way, this technology measures the actual cellular functions and processes and their changes using quantitative protein data. This is important for the investigation of cell signaling, for understanding how cells respond to stimulus, and providing potential therapeutic targets.

• Single-cell Epigenomics: This technology focuses on the changes in the individual cells’ DNA – DNA methylation and histone modifications. Epigenomic studies at the single cell level are critical for deciphering gene regulation, cell differentiation and environmental influences on gene expression. It provides information on Developmental Biology, Cancer and other systemic diseases.

• Single-cell Metabolomics: Single-cell metabolomics quantifies the metabolite content of single cells and delivers a picture of the metabolic status of an organism. These needs are: the identification of cell-to-cell metabolic variation, different activities or effects of metabolism on the cell, and the metabolic basis of diseases. It is relevant and used in cancer, immunology, and metabolic disease research.

• Single-cell Transcriptomics: Single-cell RNA sequencing expands concepts with other types of RNA data such as mRNA, non-coding RNA, and microRNA, all of which are contained in individual cells. They ensure a broad approach toward understanding basic and complex aspects of regulating gene expression, ncRNAs, and transcriptome variation between cells.

• Other Technologies: The subcategory here contains newly developing and novel single-cell methods, including single-cell ATAC-seq, single-cell ChiP-seq, and spatial transcriptomics. These technologies add another dimension of information about chromatin accessibility, protein-DNA interactions, and gene positioning in tissues.

By Application

• Cancer Research: Single cell multiomics is quickly becoming a standard approach used in cancer research based on the ability to study tumor heterogeneity, identification of cancer stem cells and clonal evolution. This application is essential for evaluating the tumor microenvironments and mechanisms of drug resistance and finding the necessary approach to cancer therapy and treatment.

• Immunology: In immunology, single-cell multi-omics is used to characterize the immune cell populations, analyzing immune responses, and identifying different immune cells associated with diseases. This application is indispensable for developing vaccines, investigating autoimmune diseases, and designing immunotherapies.

• Neurology: Single cell multiomics identifies molecular heterogeneity of neuronal and glial cell types, elucidating the nervous system architecture. This application also helps to explain the neurodevelopmental disorders, neurodegenerative diseases and cellular organization of the brain and its dysfunctions.

• Stem Cell Research: Single cell multiomics plays a vital role in stem cell research area for discriminating stem cell populations, determining differentiation processes and exploring factors that affect stem cell destiny. This application will majorly impact both regenerative medicine and developmental biology.

• Developmental Biology: In developmental biology, single cell multiomics is used to trace cell differentiation and the genetic pathways of development. This application is also valuable for Embryogenesis, organogenesis and congenital abnormalities investigation.

• Drug Discovery and Development: Single cell multiomics revolutionizes drug discovery by determining novel targets for drug intervention and mechanisms of drug action in cells, thereby enabling the prediction of cellular drug response. This application is essential for generating personalized therapies and enhancing the pharmacology of drugs.

• Other Applications: This category includes, but is not limited to, microbiology, plant biology, and environmental science. Single cell multiomics is employed in the analysis of microbial ecology, plant cell development, and effects of alterations to the external environment on cellular processes.

By End User

• Academic and Research Institutions: They are primary adopters of single cell multiomics platforms for research, both theoretical and practical. These are used to further research, output research results, and educate upcoming scientists. Their research interests touch on almost every scientific discipline, including biology and medicine, environmental sciences, etc.

• Biotechnology and Pharmaceutical Companies: In fact, these companies use single cell multiomics for drug development, biomarker identification and discoveries and development of therapeutics. It is through these technologies that they can come up with suitable targeting of boutique diseases, suitable optimizing of drug candidates as well as favorable clinical trial results which all contribute to innovation in the delivery of healthcare.

• Clinical Research Organizations: Single cell multiomics is employed by CROs to support clinical trials and research programmes. Some include sample analysis, data results analysis, and services related to compliance with the existing statutes and regulations. These organizations have vital responsibilities in transforming multiomics information into actionable knowledge.

• Hospitals and Diagnostic Laboratories: Single cell multiomics enables the identification of biomarkers for patient stratification, disease monitoring and designing personalized therapies in hospitals and diagnostic labs. These technologies help accurately identify and diagnose patients’ molecular profiles and the targeted treatment.

• Other End Users: Constitutes in this segment include research institutes in government ministries, public health departments as well as agricultural facilities. They use single-cell multiomics for multiple uses, including the public health sector, policy formation, and agriculture through knowledge of plants and animals.

Report Scope

Single Cell Multiomics Market – Regional Analysis

The single cell multiomics market is segmented across several key regions, each presenting distinct opportunities and trends:

• North America: This region continues to dominate the market for single cell multiomics solutions due to high demand from technologically developed research facilities and high funding. Some trends are a growing interest in multiomics innovative technologies, increased regulatory requirements of the quality of data, investments in precision medicine, and biomedical research.

• Europe: With some of the most complex research systems in the world, Europe demonstrates substantial increases in the consumption of single cell multiomics technologies. Germany, France, and the UK are important markets, focusing on the purity and richness of the integrated data, the complexity of the approaches applied, and the increasing coverage of multi-omics methodologies in academic and clinical investigations. The market has the advantage of constant research in the field of bioinformatics, and favorable research policies.

• Asia-Pacific: Economic development on a large scale, along with rising research budgets, enables the Asia-Pacific single cell multiomics market. Korea, China, and Japan remain the leading market growth contributors attributed to increasing investment in biotechnology, enhancement in research aspiration, and improved access to advanced research facilities. This area experiences a rise in multiomics studies owing to enhanced technologies and increasing academic partnerships.

• Latin America, Middle East, and Africa (LAMEA): Untapped markets will also be located in these regions since emerging economies powered by increased urbanization, better research facilities, and an increased understanding of multiomics technologies are expected to drive the market’s growth. Brazil, Mexico, and some regions of the Middle East are covering the potential market, showing a gradation in demand for single-cell multiomics solutions in both biomedical as well as clinical sectors. Thus, market growth has been prolonged by the demographic factor affecting population density and by the augmentation of the investments towards research facilities.

Competitive Landscape – Single Cell Multiomics Market

The Single Cell Multiomics Market is highly competitive, with many Healthcare and pharmaceutical companies operating globally. Some of the key players in the market include:

• 10x Genomics
• Illumina
• Bio-Rad Laboratories
• Fluidigm
• Becton, Dickinson and Company (BD)
• Takara Bio
• Mission Bio
• Celsee
• NanoString Technologies
• Parse Biosciences
• Scipio Bioscience
• Oxford Nanopore Technologies
• QIAGEN
• Agilent Technologies
• PerkinElmer
• Others

These companies in the Single Cell Multiomics market operate through various strategies such as product innovation, mergers and acquisitions, and partnerships.

New players entering the Single Cell Multiomics market are employing diverse strategies to penetrate and thrive alongside established firms. These strategies encompass harnessing product innovations, fulfilling market needs, and securing a competitive advantage.

Key tactics include pioneering advanced implant designs, offering tailored solutions, targeting burgeoning geographical markets, establishing competitive pricing structures, prioritizing customer-centric approaches, promoting environmentally sustainable practices, and bolstering branding and promotional efforts.

By adopting these approaches, new entrants aim to distinguish themselves, cater to evolving patient and healthcare provider requirements, and forge a robust foothold within the dynamic Single Cell Multiomics market landscape.

The Single Cell Multiomics Market is segmented as follows:

By Technology

• Single-cell RNA Sequencing (scRNA-seq)
• Single-cell DNA Sequencing (scDNA-seq)
• Single-cell Proteomics
• Single-cell Epigenomics
• Single-cell Metabolomics
• Single-cell Transcriptomics
• Other

By Application

• Cancer Research
• Immunology
• Neurology
• Stem Cell Research
• Developmental Biology
• Drug Discovery and Development
• Other

By End User

• Academic and Research Institutions
• Biotechnology and Pharmaceutical Companies
• Clinical Research Organizations
• Hospitals and Diagnostic Laboratories
• Other

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America